| 2026/09 - 九個月 人民幣(K¥) | 與去年末期 比較 | 2025/12 人民幣(K¥) | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | |
非流動資產 | ||||||
| 長期股權投資 | 6,280 | 0.00% | 6,280 | 6,353 | 6,500 | 0 |
| 投資性房地產 | 0 | -- | 0 | 0 | 0 | 0 |
| 固定資產 | 780,634 | -11.29% | 880,000 | 955,906 | 849,035 | 461,656 |
| 在建工程 | 326 | -- | 0 | 3,041 | 112,254 | 523,346 |
| 無形資產 | 13,930 | -11.34% | 15,711 | 17,514 | 15,376 | 17,233 |
| 商譽 | 30,334 | -- | 0 | 0 | 0 | 0 |
| 其他非流動資產 | 912,702 | 56.13% | 584,587 | 556,768 | 569,205 | 563,729 |
| 1,744,206 | 17.33% | 1,486,578 | 1,539,581 | 1,552,371 | 1,565,965 | |
流動資產 | ||||||
| 貨幣資金 | 310,361 | -73.04% | 1,151,045 | 1,001,327 | 1,039,366 | 651,463 |
| 應收賬款 | 1,337,139 | 9.11% | 1,225,517 | 1,298,879 | 1,410,519 | 1,287,074 |
| 存貨 | 120,414 | -14.48% | 140,807 | 176,882 | 173,536 | 153,646 |
| 其他流動資產 | 890,958 | 15,192.79% | 5,826 | 10,913 | 33,476 | 52,918 |
| 2,658,872 | 5.38% | 2,523,195 | 2,488,001 | 2,656,897 | 2,145,100 | |
流動負債 | ||||||
| 短期借款 | 0 | -100.00% | 139,896 | 186,889 | 190,914 | 109,296 |
| 應付票據 | 0 | -- | 0 | 938 | 4,000 | 17,804 |
| 應付帳款 | 1,892 | -35.91% | 2,952 | 4,966 | 3,129 | 16,338 |
| 其他流動負債 | 356,227 | 20.16% | 296,472 | 373,577 | 483,682 | 468,270 |
| 358,119 | -18.48% | 439,321 | 566,369 | 681,725 | 611,708 | |
| 流動資產淨值 | 2,300,753 | 10.41% | 2,083,875 | 1,921,632 | 1,975,173 | 1,533,392 |
| 資產總額減流動負債 | 4,044,958 | 13.29% | 3,570,452 | 3,461,213 | 3,527,543 | 3,099,357 |
非流動負債 | ||||||
| 長期借款 | 0 | -- | 0 | 0 | 0 | 15,748 |
| 應付債券 | 0 | -- | 0 | 0 | 0 | 0 |
| 其他非流動負債 | 113,752 | 244.78% | 32,993 | 13,705 | 13,492 | 7,941 |
| 113,752 | 244.78% | 32,993 | 13,705 | 13,492 | 23,689 | |
總權益 | ||||||
| 實收股本 | 129,947 | 0.00% | 129,947 | 132,947 | 134,650 | 134,650 |
| 儲備項目 | 3,571,262 | 4.81% | 3,407,513 | 3,314,562 | 3,379,401 | 2,941,018 |
| 股東權益 | 3,701,209 | 4.63% | 3,537,460 | 3,447,509 | 3,514,052 | 3,075,668 |
| 非控股權益 | 229,997 | -- | 0 | 0 | 0 | 0 |
300841 康華生物
按盤價 
51.070 +0.270 (+0.53%)
51.070 +0.270 (+0.53%)| 備註： | 報價延遲最少15分鐘，資料更新時間為 20/10/2026 16:30 |
